RDNT saw its Momentum Indicator move below the 0 level on December 09, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 84 similar instances where the indicator turned negative. In of the 84 cases, the stock moved further down in the following days. The odds of a decline are at .
The Moving Average Convergence Divergence Histogram (MACD) for RDNT turned negative on November 29, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at .
RDNT moved below its 50-day moving average on December 18, 2024 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for RDNT entered a downward trend on December 19, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RDNT's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
RDNT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RDNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.621) is normal, around the industry mean (23.300). RDNT's P/E Ratio (962.000) is considerably higher than the industry average of (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.924) is also within normal values, averaging (43.338).
a provider of medical imaging services
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RWMCX | 60.74 | 0.66 | +1.10% |
American Funds Washington Mutual R3 | |||
LRSYX | 20.96 | 0.13 | +0.62% |
Lord Abbett Small Cap Value I | |||
GGSOX | 15.87 | 0.08 | +0.51% |
Grandeur Peak Global Stalwarts Investor | |||
RTNCX | 11.18 | 0.01 | +0.09% |
Russell Inv Tax-Managed Intl Eq C | |||
FIKIX | 44.90 | -0.95 | -2.08% |
Fidelity Advisor Utilities Z |
A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with BLFS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then BLFS could also see price increases.
Ticker / NAME | Correlation To RDNT | 1D Price Change % | ||
---|---|---|---|---|
RDNT | 100% | +1.85% | ||
BLFS - RDNT | 44% Loosely correlated | +4.90% | ||
AZTA - RDNT | 39% Loosely correlated | +1.88% | ||
QTRX - RDNT | 38% Loosely correlated | +5.11% | ||
BVS - RDNT | 38% Loosely correlated | +1.43% | ||
VCYT - RDNT | 37% Loosely correlated | +4.66% | ||
More |